Trial Profile
FOLFOX vs cisplatin + fluorouracil in patients with oesophageal cancer also receiving radiotherapy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Jun 2012
Price :
$35
*
At a glance
- Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; Oxaliplatin (Primary) ; Cisplatin
- Indications Oesophageal cancer
- Focus Therapeutic Use
- Acronyms ACCORD-17; PRODIGE-5
- 05 Jun 2012 Final analysis presented at the 48th Annual Meeting of the American Society of Clinical Oncology.
- 20 Oct 2010 New trial record